Back to list

Vaccines effective against hospitalization from Delta variant


 
If you have less than a minute:
 

  • New study found vaccines are highly effective against hospitalization from Delta variant.
  • World leaders promised one billion Covid vaccine doses for poorer nations at G7 summit.

 
Read more:
 
Research

  • New analysis by PHE shows for the first time that 2 doses of COVID-19 vaccines are highly effective against hospitalisation from the Delta variant. The analysis suggests the Pfizer-BioNTech vaccine is 96% effective against hospitalisation after 2 doses, and the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses.
  • Novavax Offers the US a fourth strong vaccine, as it completed a large U.S. trial with an efficacy rate of about 90 percent. Novavax also has production facilities in the UK and similar technologies are being used for vaccines in Taiwan and Vietnam.

 
World

 
UK

  • Boris Johnson delayed lockdown easing in England due to concerns over delta Covid variant. He announced there would be a review after two weeks and he was "confident" the delay would be no longer than four weeks. This means the rules that were due to be lifted June 21 have now been pushed back to July 19. For now, gatherings are limited to six people indoors and 30 outdoors, face masks are required in public places, and nightclub and similar venues are still closed. More details here.

 
US

 
Asia

  • In Thailand, students were thrilled to go back to school on the first day of the 2021 academic year, after a long period of online learning at home.
  • Taiwan's COVID case number was below 200 for a second straight day, indicating the outbreak is easing, according to the Central Epidemic Command Center (CECC).
  • In the Philippines, Local governments may start vaccination of poor residents using excess supply.

With 28 years of professional experience,
UKEAS provides whole range of counselling service for your dream blueprint.
By continuing to use this site, you agree to the use of cookies. Click here for our full privacy policy
Accept